Select Language
Free Registration

Glycoprotein G

Product Inquiry

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyEarliest Brand NameEarliest Approval CountryEarliest IndicationEarliest Approval CompanyEarliest Approval DateIndicationClinical Trial
Technetium Tc 99m tilmanoceptNEO3-09ApprovedUniversity Of CaliforniaLymphoseek Kit, Lymphoseek, LymphoaimUnited StatesSolid tumours; Head and Neck Neoplasms; Melanoma; Carcinoma, Squamous Cell; Breast Neoplasms; Diagnostic agentsCardinal Health 414 Llc2013-03-13Arthritis, Rheumatoid; Uterine Cervical Neoplasms; Sarcoma, Kaposi; Melanoma; Endometrial Neoplasms; Diagnostic agents; Carcinoma, Squamous Cell; Colorectal Neoplasms; Breast Neoplasms; Central Nervous System Neoplasms; Liver Neoplasms; Colonic Neoplasms; Anus Neoplasms; Squamous Cell Carcinoma of Head and Neck; Rectal Neoplasms; Metabolic Dysfunction-Associated Steatotic Liver Disease; Head and Neck Neoplasms; Solid tumours; HIV Infections
Details
  • Product Inquiry
  • Marketed Drug Information
Share to:

Join UsLegalSite MapPrivacy PolicyTerms and Conditions
Website Feedback
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

order@acrobiosystems.com

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland